{"database": "lobbying", "table": "lobbying_activities", "rows": [[1727101, "27a12f46-848e-4b41-9000-48c5b50f7ecc", "Q3", "AVANIR PHARMACEUTICALS", 401103474, "AVANIR PHARMACEUTICALS", 2015, "third_quarter", "HCR", "SGR Repeal, 21st Century Cures, Specialty Tier Price Cap Legislation, Patent Reform, Health Care Quality Measures", "Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", null, 60000, 0, 0, "2015-10-07T13:08:44.280000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1727101"], "units": {}, "query_ms": 0.3235079348087311, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}